BridgeMD
New treatment option for ALS (Amyotrophic Lateral Sclerosis)
Official title Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease
ClinicalTrials.gov ID: NCT07067229
What this study is testing
- What it's testing
- Motor neuron disease (MND) is a progressive neurological disorder involving degeneration of motor neurons, leading to muscle weakness, speech and swallowing difficulties, and respiratory failure. This study aims to develop a novel treatment approach combining personalized repetitive transcranial magnetic stimulation (rTMS) with mixed reality (MR) exercise-based games (exergames) to slow disease progression and improve quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Participants aged between 18 and 80 years
- Diagnosed with any type of motor neuron disease (MND)
- Have mild to moderate severity, as assessed by the Sinaki-Mulder scale, with a severity level between 1 and 3
You likely can't join if
- History of other neurological disorders, such as stroke
- Use of ventilatory support
- Severe dementia
The study team makes the final eligibility decision.
Where it's taking place
- Bangkok, Pathumwan, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bangkok, Pathumwan, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.